Correction to: Dapagliflozin: A Review in Type 1 Diabetes

被引:0
|
作者
Julia Paik
Hannah A. Blair
机构
[1] Springer Nature,
关键词
D O I
10.1007/s40265-019-01238-2
中图分类号
学科分类号
摘要
The article Dapagliflozin: A Review in Type 1 Diabetes, written by Julia Paik and Hannah A. Blair, was originally published Online First without Open Access.
引用
收藏
页码:2011 / 2011
相关论文
共 50 条
  • [1] Correction to: Dapagliflozin: A Review in Type 2 Diabetes
    Sohita Dhillon
    [J]. Drugs, 2019, 79 (18) : 2013 - 2013
  • [2] Dapagliflozin: A Review in Type 1 Diabetes
    Paik, Julia
    Blair, Hannah A.
    [J]. DRUGS, 2019, 79 (17) : 1877 - 1884
  • [3] Dapagliflozin: A Review in Type 1 Diabetes
    Julia Paik
    Hannah A. Blair
    [J]. Drugs, 2019, 79 : 1877 - 1884
  • [4] Dapagliflozin: A Review in Type 2 Diabetes
    Dhillon, Sohita
    [J]. DRUGS, 2019, 79 (10) : 1135 - 1146
  • [5] Dapagliflozin: A Review in Type 2 Diabetes
    Sohita Dhillon
    [J]. Drugs, 2019, 79 : 1135 - 1146
  • [6] Correction of anemia by dapagliflozin in patients with type 2 diabetes
    Stefansson, Bergur V.
    Heerspink, Hiddo J. L.
    Wheeler, David C.
    Sjostrom, C. David
    Greasley, Peter J.
    Sartipy, Peter
    Cain, Valerie
    Correa-Rotter, Ricardo
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2020, 34 (12)
  • [7] Dapagliflozin: A Review in Type 1 Diabetes (vol 79, pg 1877, 2019)
    Paik, Julia
    Blair, Hannah A.
    [J]. DRUGS, 2019, 79 (18) : 2011 - 2011
  • [8] Dapagliflozin for the treatment of type 1 diabetes mellitus
    Pafili, Kalliopi
    Maltezos, Efstratios
    Papanas, Nikolaos
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (07) : 873 - 881
  • [10] Saxagliptin/Dapagliflozin: A Review in Type 2 Diabetes Mellitus
    Karly P. Garnock-Jones
    [J]. Drugs, 2017, 77 : 319 - 330